-+ 0.00%
-+ 0.00%
-+ 0.00%

Elutia Confirms That The Ongoing Global Tariff Environment Has Had No Material Impact On Its Commercial Or Operational Performance.

Benzinga·04/14/2025 12:09:47
Listen to the news

Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix products, today confirmed that the ongoing global tariff environment has had no material impact on its commercial or operational performance.

Elutia sources, manufactures, and distributes 100% of its products within the United States, primarily from its Roswell, Georgia production facility and U.S.-based suppliers. These products include EluPro™, CanGaroo®, SimpliDerm®, and its full Cardiovascular portfolio. Furthermore, all Elutia product sales occur within the United States.